6-substituted 2,4-diamino-5-(4-carbethoxyphenylazo)pyrimidines as potential precursors of tetrahydropteridine antimetabolites.
D000818:Animals; D001391:Azo Compounds / Q000494:pharmacology*; D001835:Body Weight / Q000187:drug effects*; D002625:Chemistry, Organic; D004798:Enzymes / Q000494:pharmacology*; D008099:Liver / Q000378:metabolism; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D051379:Mice; D055601:Organic Chemistry Phenomena; D010088:Oxidoreductases / Q000096:biosynthesis*; D011743:Pyrimidines / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy*
D001391:Azo Compounds; D004798:Enzymes; D011743:Pyrimidines; D010088:Oxidoreductases